123 related articles for article (PubMed ID: 22767220)
1. Anti-tumor effect of SLPI on mammary but not colon tumor growth.
Amiano NO; Costa MJ; Reiteri RM; Payés C; Guerrieri D; Tateosian NL; Sánchez ML; Maffia PC; Diament M; Karas R; Orqueda A; Rizzo M; Alaniz L; Mazzolini G; Klein S; Sallenave JM; Chuluyan HE
J Cell Physiol; 2013 Feb; 228(2):469-75. PubMed ID: 22767220
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth.
Amiano N; Reiteri RM; Costa MJ; Tateosian N; Chuluyan HE
Cancer Immunol Immunother; 2011 Jun; 60(6):895-900. PubMed ID: 21519828
[TBL] [Abstract][Full Text] [Related]
3. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
4. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
[TBL] [Abstract][Full Text] [Related]
5. Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth.
Kiewlich D; Zhang J; Gross C; Xia W; Larsen B; Cobb RR; Biroc S; Gu JM; Sato T; Light DR; Heitner T; Willuda J; Vogel D; Monteclaro F; Citkowicz A; Roffler SR; Zajchowski DA
Neoplasia; 2006 Jan; 8(1):18-30. PubMed ID: 16533422
[TBL] [Abstract][Full Text] [Related]
6. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
[TBL] [Abstract][Full Text] [Related]
7. Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma.
Chen J; Yang B; Zhang S; Ling Y; Ye J; Jia Z; Cao J
Cancer Gene Ther; 2012 May; 19(5):328-35. PubMed ID: 22388454
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
9. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.
Yu HK; Ahn JH; Lee HJ; Lee SK; Hong SW; Yoon Y; Kim JS
J Gene Med; 2005 Jan; 7(1):39-49. PubMed ID: 15517541
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukocyte protease inhibitor in cancer development.
Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
[TBL] [Abstract][Full Text] [Related]
11. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of secretory leucocyte protease inhibitor in colon carcinoma].
Guo J; Li G; Zhuang J; Ji C; Liu F; Tao G; Dong H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):898-901. PubMed ID: 23803207
[TBL] [Abstract][Full Text] [Related]
13. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
[TBL] [Abstract][Full Text] [Related]
15. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
Peters MG; Farías E; Colombo L; Filmus J; Puricelli L; Bal de Kier Joffé E
Breast Cancer Res Treat; 2003 Jul; 80(2):221-32. PubMed ID: 12908826
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
[TBL] [Abstract][Full Text] [Related]
18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
19. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
[TBL] [Abstract][Full Text] [Related]
20. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
